Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 64-68 , 15 April 2010

Evaluation of patients with Clinically Unclear Parkinsonian Syndromes submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1

  • Andre C. Felicio

      Affiliations

    • Department of Neurology and Neurosurgery, Movement Disorder Unit, Federal University of São Paulo, Sao Paulo, Brazil
    • Laboratório Interdisciplinar de Neurociências Clínicas, Federal University of São Paulo, Sao Paulo, Brazil
    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Department of Neurology at Rua Pedro de Toledo 650, Vila Clementino, Sao Paulo-SP, Postal Code 04039-002, Brazil. Tel.: +55 11 5575 5240; fax: +55 11 5081 5005.
    • ,
  • Clecio Godeiro-Junior

      Affiliations

    • Department of Neurology and Neurosurgery, Movement Disorder Unit, Federal University of São Paulo, Sao Paulo, Brazil
    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • ,
  • Ming C. Shih

      Affiliations

    • Laboratório Interdisciplinar de Neurociências Clínicas, Federal University of São Paulo, Sao Paulo, Brazil
    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • ,
  • Vanderci Borges

      Affiliations

    • Department of Neurology and Neurosurgery, Movement Disorder Unit, Federal University of São Paulo, Sao Paulo, Brazil
    • ,
  • Sônia M.A. Silva

      Affiliations

    • Department of Neurology and Neurosurgery, Movement Disorder Unit, Federal University of São Paulo, Sao Paulo, Brazil
    • ,
  • Patrícia de Carvalho Aguiar

      Affiliations

    • Department of Neurology and Neurosurgery, Movement Disorder Unit, Federal University of São Paulo, Sao Paulo, Brazil
    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • ,
  • Marcelo Q. Hoexter

      Affiliations

    • Laboratório Interdisciplinar de Neurociências Clínicas, Federal University of São Paulo, Sao Paulo, Brazil
    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • ,
  • Orlando G.P. Barsottini

      Affiliations

    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • ,
  • Luiz A.F. Andrade

      Affiliations

    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • ,
  • Rodrigo A. Bressan

      Affiliations

    • Laboratório Interdisciplinar de Neurociências Clínicas, Federal University of São Paulo, Sao Paulo, Brazil
    • Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    • ,
  • Henrique B. Ferraz

      Affiliations

    • Department of Neurology and Neurosurgery, Movement Disorder Unit, Federal University of São Paulo, Sao Paulo, Brazil

Received 12 September 2009 ,Revised 15 October 2009 ,Accepted 22 December 2009.

References 

  1. Michell AW, Lewis SJ, Foltynie T, Barker RA. Biomarkers and Parkinson's disease. Brain. 2004;127:1693–1705
  2. Bressan RA, Shih MC, Hoexter MQ, Lacerda AL. Can molecular imaging techniques identify biomarkers for neuropsychiatric disorders?. Rev Bras Psiquiatr. 2007;29:102–104
  3. Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005;64:208–215
  4. Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, et al. Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord. 2007;22:1229–1238
  5. Catafau AM, Tolosa E. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord. 2004;19:1175–1182
  6. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 2001;57:34–38
  7. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184
  8. Brooks DJ. Technology insight: imaging neurodegeneration in Parkinson's disease. Nat Clin Pract Neurol. 2008;4:267–277
  9. Kung HF, Kung MP, Wey SP, Lin KJ, Yen TC. Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT. Nucl Med Biol. 2007;34:787–789
  10. Van Laere K, Everaert L, Annemans L, Gonce M, Vandenberghe W, Vander Borght T. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging. 2008;35:1367–1376
  11. Shih MC, Franco de Andrade LA, Amaro E, Felicio AC, Ferraz HB, Wagner J, et al. Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?-a [99mTc]-TRODAT-1 SPECT study. Mov Disord. 2007;22:863–866
  12. Barsottini OG, Felicio AC, Aguiar Pde C, Godeiro-Junior C, Shih MC, Hoexter MQ. Clinical and molecular neuroimaging characteristics of Brazilian patients with Parkinson's disease and mutations in PARK2 or PARK8 genes. Arq Neuropsiquiatr. 2009;67:7–11
  13. Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K. (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol. 2004;61:1224–1229
  14. Tolosa E, Borght TV, Moreno E. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov Disord. 2007;22:2346–2351
  15. Marshall VL, Reininger CB, Marquardt M, Patterson J, Hadley DM, Oertel WH, et al. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord. 2009;24:500–508
  16. Plotkin M, Wurm R, Eisenacher J, Szerewicz K, Michel R, Schlenger L, et al. Combined SPECT/CT imaging using 123I-IMT in the detection of recurrent or persistent head and neck cancer. Eur Radiol. 2006;16:503–511
  17. Vlaar AM, de Nijs T, Kessels AG, Vreeling FW, Winogrodzka A, Mess WH, et al. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. Eur Neurol. 2008;59:258–266
  18. Bairactaris C, Demakopoulos N, Tripsianis G, Sioka C, Farmakiotis D, Vadikolias K, et al. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes. J Clin Neurosci. 2009;16:246–252
  19. Mozley PD, Schneider JS, Acton PD, Plossl K, Stern MB, Siderowf A, et al. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med. 2000;41:584–589
  20. Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED. Rest tremor in patients with Essential Tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol. 2003;60:405–410
  21. Hesse S, Oehlwein C, Barthel H, Schwarz J, Polster D, Wagner A, et al. Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. J Neural Transm. 2006;113:1177–1190
  22. Felicio AC, Shih MC, Godeiro-Junior C, Andrade LA, Bressan RA, Ferraz HB. Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty. Neurologist. 2009;15:6–16
  23. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA. 2002;287:1653–1661
  24. Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol. 2003;54:93–101
  25. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med. 2004;351:2498–2508
  26. Winogrodzka A, Wagenaar RC, Bergmans P, Vellinga A, Booij J, van Royen EA, et al. Rigidity decreases resting tremor intensity in Parkinson's disease: a [(123)I]beta-CIT SPECT study in early, nonmedicated patients. Mov Disord. 2001;16:1033–1040

PII: S0022-510X(10)00003-1

doi: 10.1016/j.jns.2009.12.024

Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 64-68 , 15 April 2010

Article Tools